Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrogel for prevention of breast cancer skin inflammation during radiotherapy
IRCT20241018063405N1Phase 3Completed
- Sponsor
- Fidar Darou
- Start
- Oct 2024
- Countries
- 1
01
Overview
Phase 3 trial of nepidermin in radiodermatitis and breast cancer, sponsored by Fidar Darou. Started Oct 2024; status: completed.
02
Drugs
nepidermin
03
Conditions
radiodermatitisbreast cancer
Beyond the preview
Go deeper on IRCT20241018063405N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241018063405N1.